281 related articles for article (PubMed ID: 11927949)
1. In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens.
Dickinson AM; Wang XN; Sviland L; Vyth-Dreese FA; Jackson GH; Schumacher TN; Haanen JB; Mutis T; Goulmy E
Nat Med; 2002 Apr; 8(4):410-4. PubMed ID: 11927949
[TBL] [Abstract][Full Text] [Related]
2. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
[TBL] [Abstract][Full Text] [Related]
3. [Minor antigens - major impact. The role of minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation].
Hudecek M; Bartsch K; Tschiedel S; Niederwieser D
Dtsch Med Wochenschr; 2008 Jul; 133(28-29):1511-6. PubMed ID: 18597211
[TBL] [Abstract][Full Text] [Related]
4. Exogenous Addition of Minor H Antigen HA-1+ Dendritic Cells to Skin Tissues Ex Vivo Causes Infiltration and Activation of HA-1-Specific Cytotoxic T Cells.
Kim YH; Vyth-Dreese FA; Schrama E; Pavel S; Bajema I; Goulmy E; Spierings E
Biol Blood Marrow Transplant; 2011 Jan; 17(1):69-77. PubMed ID: 20708701
[TBL] [Abstract][Full Text] [Related]
5. Targeting haematopoietic-specific minor histocompatibility antigens to distinguish graft-versus-tumour effects from graft-versus-host disease.
Spaapen R; Mutis T
Best Pract Res Clin Haematol; 2008 Sep; 21(3):543-57. PubMed ID: 18790454
[TBL] [Abstract][Full Text] [Related]
6. Peptide length extension skews the minor HA-1 antigen presentation toward activated dendritic cells but reduces its presentation efficiency.
Hambach L; Aghai Z; Pool J; Kröger N; Goulmy E
J Immunol; 2010 Oct; 185(8):4582-9. PubMed ID: 20855877
[TBL] [Abstract][Full Text] [Related]
7. Targeting a single mismatched minor histocompatibility antigen with tumor-restricted expression eradicates human solid tumors.
Hambach L; Vermeij M; Buser A; Aghai Z; van der Kwast T; Goulmy E
Blood; 2008 Sep; 112(5):1844-52. PubMed ID: 18544677
[TBL] [Abstract][Full Text] [Related]
8. Analysis of immunodominance among minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation.
Mori S; El-Baki H; Mullen CA
Bone Marrow Transplant; 2003 May; 31(10):865-75. PubMed ID: 12748663
[TBL] [Abstract][Full Text] [Related]
9. Conservation of minor histocompatibility antigens between human and non-human primates.
den Haan JM; Bontrop RE; Pool J; Sherman N; Blokland E; Engelhard VH; Hunt DF; Goulmy E
Eur J Immunol; 1996 Nov; 26(11):2680-5. PubMed ID: 8921955
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens.
Mutis T; Verdijk R; Schrama E; Esendam B; Brand A; Goulmy E
Blood; 1999 Apr; 93(7):2336-41. PubMed ID: 10090944
[TBL] [Abstract][Full Text] [Related]
11. Single-cell cloning of human, donor-derived antileukemia T-cell lines for in vitro separation of graft-versus-leukemia effect from graft-versus-host reaction.
Montagna D; Daudt L; Locatelli F; Montini E; Turin I; Lisini D; Giorgiani G; Bernardo ME; Maccario R
Cancer Res; 2006 Jul; 66(14):7310-6. PubMed ID: 16849581
[TBL] [Abstract][Full Text] [Related]
12. Refinement of molecular approaches to improve the chance of identification of hematopoietic-restricted minor histocompatibility antigens.
de Rijke B; van Horssen-Zoetbrood A; Veenbergen S; Fredrix H; de Witte T; van de Wiel-van Kemenade E; Dolstra H
J Immunol Methods; 2008 Jan; 329(1-2):125-37. PubMed ID: 17996247
[TBL] [Abstract][Full Text] [Related]
13. The human cathepsin H gene encodes two novel minor histocompatibility antigen epitopes restricted by HLA-A*3101 and -A*3303.
Torikai H; Akatsuka Y; Miyazaki M; Tsujimura A; Yatabe Y; Kawase T; Nakao Y; Tsujimura K; Motoyoshi K; Morishima Y; Kodera Y; Kuzushima K; Takahashi T
Br J Haematol; 2006 Aug; 134(4):406-16. PubMed ID: 16822283
[TBL] [Abstract][Full Text] [Related]
14. Possible role of minor h antigens in the persistence of donor chimerism after stem cell transplantation; relevance for sustained leukemia remission.
van der Torren CR; van Hensbergen Y; Luther S; Aghai Z; Rychnavská ZS; Slot M; Scherjon S; Kröger N; Ganser A; Weissinger EM; Goulmy E; Hambach L
PLoS One; 2015; 10(3):e0119595. PubMed ID: 25774796
[TBL] [Abstract][Full Text] [Related]
15. The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.
Vogt MH; van den Muijsenberg JW; Goulmy E; Spierings E; Kluck P; Kester MG; van Soest RA; Drijfhout JW; Willemze R; Falkenburg JH
Blood; 2002 Apr; 99(8):3027-32. PubMed ID: 11929796
[TBL] [Abstract][Full Text] [Related]
16. Detection of microchimerism by minor histocompatibility antigen HA-1 allele-specific nested polymerase chain reaction.
Wieles B; Pool J; Derks R; Burlingham WJ; Goulmy E
Biol Blood Marrow Transplant; 2005 May; 11(5):345-8. PubMed ID: 15846287
[TBL] [Abstract][Full Text] [Related]
17. The HLA-A*0201-restricted minor histocompatibility antigen HA-1H peptide can also be presented by another HLA-A2 subtype, A*0206.
Torikai H; Akatsuka Y; Miyauchi H; Terakura S; Onizuka M; Tsujimura K; Miyamura K; Morishima Y; Kodera Y; Kuzushima K; Takahashi T
Bone Marrow Transplant; 2007 Jul; 40(2):165-74. PubMed ID: 17530010
[TBL] [Abstract][Full Text] [Related]
18. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF
Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014
[TBL] [Abstract][Full Text] [Related]
19. Adult and cord blood T cells can acquire HA-1 specificity through HA-1 T-cell receptor gene transfer.
Mommaas B; van Halteren AG; Pool J; van der Veken L; Wieles B; Heemskerk MH; Goulmy E
Haematologica; 2005 Oct; 90(10):1415-21. PubMed ID: 16219579
[TBL] [Abstract][Full Text] [Related]
20. Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1.
Oostvogels R; Minnema MC; van Elk M; Spaapen RM; te Raa GD; Giovannone B; Buijs A; van Baarle D; Kater AP; Griffioen M; Spierings E; Lokhorst HM; Mutis T
Leukemia; 2013 Mar; 27(3):642-9. PubMed ID: 23079962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
